Contraception. 2018 Apr 07; doi: 10.1016/j.contraception.2018.03.035. Epub 2018 Apr 07.
Can inhibition of retinoic acid biosynthesis function as a non-hormonal female contraceptive?.
Contraception
Jisun Paik, Piper M Treuting, Michael Haenisch, John K Amory
Affiliations
Affiliations
- Department of Comparative Medicine, University of Washington, Seattle, WA, USA. Electronic address: [email protected].
- Department of Comparative Medicine, University of Washington, Seattle, WA, USA.
- Department of Medicine, University of Washington, Seattle, WA, USA.
PMID: 29630869
PMCID: PMC6174106 DOI: 10.1016/j.contraception.2018.03.035
Abstract
OBJECTIVE: Vitamin A deficient females have reduced fertility due to decreased retinoic acid production. WIN 18,446 inhibits retinoic acid biosynthesis and functions as a contraceptive in males. We tested whether WIN 18,446 treatment would suppress fertility in female mice.
STUDY DESIGN: Female mice were treated with WIN 18,446 and mated. Pregnancy rates were compared using Fisher's exact test.
RESULTS: WIN 18,446 reduced pregnancy compared with control (p=.03). However, one animal became pregnant with malformed embryos.
CONCLUSIONS: WIN 18,446 treatment significantly reduces fecundity, but teratogenicity in the setting of contraceptive failure limits the appeal of this approach to female contraception.
Copyright © 2018 Elsevier Inc. All rights reserved.
Keywords: aldehyde dehydrogenase 1A; enzyme inhibitor; pregnancy; retinoic acid
References
- J Androl. 2011 Jan-Feb;32(1):111-9 - PubMed
- Am J Obstet Gynecol. 1974 Jul 1;119(5):583-8 - PubMed
- Annu Rev Nutr. 2002;22:347-81 - PubMed
- Biol Reprod. 2016 Sep;95(3):70 - PubMed
- Hum Reprod. 2010 Oct;25(10):2579-90 - PubMed
- J Biol Chem. 2014 May 23;289(21):15104-17 - PubMed
- Endocrinology. 2016 May;157(5):2160-72 - PubMed
- Cell. 1995 Dec 15;83(6):859-69 - PubMed
- Teratology. 1978 Aug;18(1):5-15 - PubMed
Publication Types
Grant support